ID PA22A_BUNCA Reviewed; 14 AA. AC P84472; DT 12-APR-2005, integrated into UniProtKB/Swiss-Prot. DT 12-APR-2005, sequence version 1. DT 16-JUN-2009, entry version 18. DE RecName: Full=Phospholipase A2, neurotoxin T1-2 A chain; DE EC=3.1.1.4; DE AltName: Full=Phosphatidylcholine 2-acylhydrolase T1-2 A; DE Flags: Fragment; OS Bungarus candidus (Malayan krait). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Lepidosauria; Squamata; Scleroglossa; Serpentes; Colubroidea; OC Elapidae; Bungarinae; Bungarus. OX NCBI_TaxID=92438; RN [1] RP PROTEIN SEQUENCE, FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, TISSUE RP SPECIFICITY, AND LETHAL DOSE. RC TISSUE=Venom; RX PubMed=14769867; DOI=10.1093/jb/mvg187; RA Khow O., Chanhome L., Omori-Satoh T., Ogawa Y., Yanoshita R., RA Samejima Y., Kuch U., Mebs D., Sitprija V.; RT "Isolation, toxicity and amino terminal sequences of three major RT neurotoxins in the venom of Malayan krait (Bungarus candidus) from RT Thailand."; RL J. Biochem. 134:799-804(2003). CC -!- FUNCTION: Neurotoxin T1-2 is a presynaptic neurotoxin of the venom CC that exhibits indirect hemolytic activity against human CC erythrocytes. PA2 catalyzes the calcium-dependent hydrolysis of CC the 2-acyl groups in 3-sn-phosphoglycerides. Inhibits CC neuromuscular transmission by blocking acetylcholine release from CC the nerve termini. CC -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1- CC acylglycerophosphocholine + a carboxylate. CC -!- COFACTOR: Binds 1 calcium ion (By similarity). CC -!- SUBUNIT: Heterodimer; disulfide-linked. The A chains have CC phospholipase A2 activity and the B chains show homology with the CC basic protease inhibitors. CC -!- SUBCELLULAR LOCATION: Secreted. CC -!- TISSUE SPECIFICITY: Expressed by the venom gland. CC -!- TOXIC DOSE: LD(50) is 0.22 mg/kg by intravenous injection in mice. CC -!- SIMILARITY: Belongs to the phospholipase A2 family. Group I CC subfamily. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR HOVERGEN; P84472; -. DR BRENDA; 3.1.1.4; 291622. DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell. DR GO; GO:0042734; C:presynaptic membrane; IEA:UniProtKB-KW. DR GO; GO:0005509; F:calcium ion binding; IEA:UniProtKB-KW. DR GO; GO:0004623; F:phospholipase A2 activity; IEA:EC. DR GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW. DR GO; GO:0009405; P:pathogenesis; IEA:UniProtKB-KW. DR GO; GO:0007268; P:synaptic transmission; IEA:UniProtKB-KW. DR InterPro; IPR013090; Phospholipase_A2_AS. DR PROSITE; PS00119; PA2_ASP; PARTIAL. DR PROSITE; PS00118; PA2_HIS; PARTIAL. PE 1: Evidence at protein level; KW Calcium; Direct protein sequencing; Disulfide bond; Hydrolase; KW Lipid degradation; Neurotoxin; Presynaptic neurotoxin; Secreted; KW Toxin. FT CHAIN 1 >14 Phospholipase A2, neurotoxin T1-2 A FT chain. FT /FTId=PRO_0000161631. FT NON_TER 14 14 SQ SEQUENCE 14 AA; 1816 MW; 6E91DBA06720A09B CRC64; NLYQFKEMIR YTIP //